Cargando…
Leishmaniasis Vaccine: Where are We Today?
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fatal systemic infection. WHO has classified the disease as emerging and uncontrolled and estimates that the infection results in two million new cases a year. There are 12 million people currently infe...
Autor principal: | Kedzierski, Lukasz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889658/ https://www.ncbi.nlm.nih.gov/pubmed/20606974 http://dx.doi.org/10.4103/0974-777X.62881 |
Ejemplares similares
-
Immunological Perspectives of Leishmaniasis
por: Nylén, Susanne, et al.
Publicado: (2010) -
Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010) -
Drug Resistance in Leishmaniasis
por: Chakravarty, Jaya, et al.
Publicado: (2010) -
A Current Perspective on Leishmaniasis
por: Clem, Angela
Publicado: (2010) -
The Biology and Control of Leishmaniasis Vectors
por: Claborn, David M
Publicado: (2010)